Evaluating the Feasibility of a Telescreening Program for Retinopathy of Prematurity (ROP) in Denmark

: This study investigates the feasibility of implementing telescreening for retinopathy of prematurity (ROP) using the ICON GO widefield camera operated by a non-physician healthcare professional (NPHP). We hypothesized that images captured by an NPHP are adequate to evaluate ROP changes without fur...

Full description

Saved in:
Bibliographic Details
Published in:Journal of personalized medicine Vol. 14; no. 10; p. 1020
Main Authors: Al-Abaiji, Hajer A, Bangsgaard, Regitze, Kofod, Mads, Faber, Carsten, Larsen, Ann-Cathrine, Brost, Agnes Galbo, Slidsborg, Carina, Klemp, Kristian, Breindahl, Morten, la Cour, Morten Dornonville de, Kessel, Line
Format: Journal Article
Language:English
Published: Switzerland MDPI AG 24-09-2024
MDPI
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract : This study investigates the feasibility of implementing telescreening for retinopathy of prematurity (ROP) using the ICON GO widefield camera operated by a non-physician healthcare professional (NPHP). We hypothesized that images captured by an NPHP are adequate to evaluate ROP changes without further examinations. Secondly, the level of agreement between independent ROP graders were evaluated based on the fundus photographs. : National ROP screening criteria were gestational age (GA) < 32 weeks or birthweight (BW) < 1500 g. Exclusion criteria were children hospitalized and born outside the Capital Region and examinations not performed by an NPHP. The screenings were performed using the ICON GO . The NPHP selected the best images for evaluation by an -site ophthalmologist, regarding whether re-examination was necessary and if so, whether the re-examination was beneficial. Lastly, the images were re-evaluated by an independent -site ophthalmologist. : A total of 415 screening sessions on 165 patients performed by an NPHP were included. Re-examination was necessary in three screening sessions and beneficial in two. The level of agreement between the -site and -site ophthalmologists regarding ROP screening outcome was = 0.82, ROP stage = 0.69, plus disease = 0.69, and lastly ROP zone = 0.37. Of the screened children, ninety-seven (58.8%) had no ROP at any time points, sixty-two (37.6%) had some stage of ROP not requiring treatment, and six (3.6%) received ROP treatment. : Telemedicine screening for ROP with the ICON GO camera performed by an NPHP was feasible with an almost-perfect agreement and negligible need for re-examinations. The approach effectively identified children needing treatment, supporting the use of telescreening in ROP management.
AbstractList Objectives: This study investigates the feasibility of implementing telescreening for retinopathy of prematurity (ROP) using the ICON GO® widefield camera operated by a non-physician healthcare professional (NPHP). We hypothesized that images captured by an NPHP are adequate to evaluate ROP changes without further examinations. Secondly, the level of agreement between independent ROP graders were evaluated based on the fundus photographs. Methods: National ROP screening criteria were gestational age (GA) < 32 weeks or birthweight (BW) < 1500 g. Exclusion criteria were children hospitalized and born outside the Capital Region and examinations not performed by an NPHP. The screenings were performed using the ICON GO®. The NPHP selected the best images for evaluation by an on-site ophthalmologist, regarding whether re-examination was necessary and if so, whether the re-examination was beneficial. Lastly, the images were re-evaluated by an independent off-site ophthalmologist. Results: A total of 415 screening sessions on 165 patients performed by an NPHP were included. Re-examination was necessary in three screening sessions and beneficial in two. The level of agreement between the on-site and off-site ophthalmologists regarding ROP screening outcome was k = 0.82, ROP stage k = 0.69, plus disease k = 0.69, and lastly ROP zone k = 0.37. Of the screened children, ninety-seven (58.8%) had no ROP at any time points, sixty-two (37.6%) had some stage of ROP not requiring treatment, and six (3.6%) received ROP treatment. Conclusions: Telemedicine screening for ROP with the ICON GO® camera performed by an NPHP was feasible with an almost-perfect agreement and negligible need for re-examinations. The approach effectively identified children needing treatment, supporting the use of telescreening in ROP management.Objectives: This study investigates the feasibility of implementing telescreening for retinopathy of prematurity (ROP) using the ICON GO® widefield camera operated by a non-physician healthcare professional (NPHP). We hypothesized that images captured by an NPHP are adequate to evaluate ROP changes without further examinations. Secondly, the level of agreement between independent ROP graders were evaluated based on the fundus photographs. Methods: National ROP screening criteria were gestational age (GA) < 32 weeks or birthweight (BW) < 1500 g. Exclusion criteria were children hospitalized and born outside the Capital Region and examinations not performed by an NPHP. The screenings were performed using the ICON GO®. The NPHP selected the best images for evaluation by an on-site ophthalmologist, regarding whether re-examination was necessary and if so, whether the re-examination was beneficial. Lastly, the images were re-evaluated by an independent off-site ophthalmologist. Results: A total of 415 screening sessions on 165 patients performed by an NPHP were included. Re-examination was necessary in three screening sessions and beneficial in two. The level of agreement between the on-site and off-site ophthalmologists regarding ROP screening outcome was k = 0.82, ROP stage k = 0.69, plus disease k = 0.69, and lastly ROP zone k = 0.37. Of the screened children, ninety-seven (58.8%) had no ROP at any time points, sixty-two (37.6%) had some stage of ROP not requiring treatment, and six (3.6%) received ROP treatment. Conclusions: Telemedicine screening for ROP with the ICON GO® camera performed by an NPHP was feasible with an almost-perfect agreement and negligible need for re-examinations. The approach effectively identified children needing treatment, supporting the use of telescreening in ROP management.
Objectives: This study investigates the feasibility of implementing telescreening for retinopathy of prematurity (ROP) using the ICON GO® widefield camera operated by a non-physician healthcare professional (NPHP). We hypothesized that images captured by an NPHP are adequate to evaluate ROP changes without further examinations. Secondly, the level of agreement between independent ROP graders were evaluated based on the fundus photographs. Methods: National ROP screening criteria were gestational age (GA) < 32 weeks or birthweight (BW) < 1500 g. Exclusion criteria were children hospitalized and born outside the Capital Region and examinations not performed by an NPHP. The screenings were performed using the ICON GO®. The NPHP selected the best images for evaluation by an on-site ophthalmologist, regarding whether re-examination was necessary and if so, whether the re-examination was beneficial. Lastly, the images were re-evaluated by an independent off-site ophthalmologist. Results: A total of 415 screening sessions on 165 patients performed by an NPHP were included. Re-examination was necessary in three screening sessions and beneficial in two. The level of agreement between the on-site and off-site ophthalmologists regarding ROP screening outcome was k = 0.82, ROP stage k = 0.69, plus disease k = 0.69, and lastly ROP zone k = 0.37. Of the screened children, ninety-seven (58.8%) had no ROP at any time points, sixty-two (37.6%) had some stage of ROP not requiring treatment, and six (3.6%) received ROP treatment. Conclusions: Telemedicine screening for ROP with the ICON GO® camera performed by an NPHP was feasible with an almost-perfect agreement and negligible need for re-examinations. The approach effectively identified children needing treatment, supporting the use of telescreening in ROP management.
: This study investigates the feasibility of implementing telescreening for retinopathy of prematurity (ROP) using the ICON GO widefield camera operated by a non-physician healthcare professional (NPHP). We hypothesized that images captured by an NPHP are adequate to evaluate ROP changes without further examinations. Secondly, the level of agreement between independent ROP graders were evaluated based on the fundus photographs. : National ROP screening criteria were gestational age (GA) < 32 weeks or birthweight (BW) < 1500 g. Exclusion criteria were children hospitalized and born outside the Capital Region and examinations not performed by an NPHP. The screenings were performed using the ICON GO . The NPHP selected the best images for evaluation by an -site ophthalmologist, regarding whether re-examination was necessary and if so, whether the re-examination was beneficial. Lastly, the images were re-evaluated by an independent -site ophthalmologist. : A total of 415 screening sessions on 165 patients performed by an NPHP were included. Re-examination was necessary in three screening sessions and beneficial in two. The level of agreement between the -site and -site ophthalmologists regarding ROP screening outcome was = 0.82, ROP stage = 0.69, plus disease = 0.69, and lastly ROP zone = 0.37. Of the screened children, ninety-seven (58.8%) had no ROP at any time points, sixty-two (37.6%) had some stage of ROP not requiring treatment, and six (3.6%) received ROP treatment. : Telemedicine screening for ROP with the ICON GO camera performed by an NPHP was feasible with an almost-perfect agreement and negligible need for re-examinations. The approach effectively identified children needing treatment, supporting the use of telescreening in ROP management.
Objectives : This study investigates the feasibility of implementing telescreening for retinopathy of prematurity (ROP) using the ICON GO ® widefield camera operated by a non-physician healthcare professional (NPHP). We hypothesized that images captured by an NPHP are adequate to evaluate ROP changes without further examinations. Secondly, the level of agreement between independent ROP graders were evaluated based on the fundus photographs. Methods : National ROP screening criteria were gestational age (GA) < 32 weeks or birthweight (BW) < 1500 g. Exclusion criteria were children hospitalized and born outside the Capital Region and examinations not performed by an NPHP. The screenings were performed using the ICON GO ® . The NPHP selected the best images for evaluation by an on -site ophthalmologist, regarding whether re-examination was necessary and if so, whether the re-examination was beneficial. Lastly, the images were re-evaluated by an independent off -site ophthalmologist. Results : A total of 415 screening sessions on 165 patients performed by an NPHP were included. Re-examination was necessary in three screening sessions and beneficial in two. The level of agreement between the on -site and off -site ophthalmologists regarding ROP screening outcome was k = 0.82, ROP stage k = 0.69, plus disease k = 0.69, and lastly ROP zone k = 0.37. Of the screened children, ninety-seven (58.8%) had no ROP at any time points, sixty-two (37.6%) had some stage of ROP not requiring treatment, and six (3.6%) received ROP treatment. Conclusions : Telemedicine screening for ROP with the ICON GO ® camera performed by an NPHP was feasible with an almost-perfect agreement and negligible need for re-examinations. The approach effectively identified children needing treatment, supporting the use of telescreening in ROP management.
Objectives: This study investigates the feasibility of implementing telescreening for retinopathy of prematurity (ROP) using the ICON GO[sup.®] widefield camera operated by a non-physician healthcare professional (NPHP). We hypothesized that images captured by an NPHP are adequate to evaluate ROP changes without further examinations. Secondly, the level of agreement between independent ROP graders were evaluated based on the fundus photographs. Methods: National ROP screening criteria were gestational age (GA) < 32 weeks or birthweight (BW) < 1500 g. Exclusion criteria were children hospitalized and born outside the Capital Region and examinations not performed by an NPHP. The screenings were performed using the ICON GO[sup.®]. The NPHP selected the best images for evaluation by an on-site ophthalmologist, regarding whether re-examination was necessary and if so, whether the re-examination was beneficial. Lastly, the images were re-evaluated by an independent off-site ophthalmologist. Results: A total of 415 screening sessions on 165 patients performed by an NPHP were included. Re-examination was necessary in three screening sessions and beneficial in two. The level of agreement between the on-site and off-site ophthalmologists regarding ROP screening outcome was k = 0.82, ROP stage k = 0.69, plus disease k = 0.69, and lastly ROP zone k = 0.37. Of the screened children, ninety-seven (58.8%) had no ROP at any time points, sixty-two (37.6%) had some stage of ROP not requiring treatment, and six (3.6%) received ROP treatment. Conclusions: Telemedicine screening for ROP with the ICON GO[sup.®] camera performed by an NPHP was feasible with an almost-perfect agreement and negligible need for re-examinations. The approach effectively identified children needing treatment, supporting the use of telescreening in ROP management.
Audience Academic
Author Slidsborg, Carina
Bangsgaard, Regitze
Faber, Carsten
Klemp, Kristian
Kofod, Mads
Breindahl, Morten
Brost, Agnes Galbo
la Cour, Morten Dornonville de
Larsen, Ann-Cathrine
Al-Abaiji, Hajer A
Kessel, Line
AuthorAffiliation 1 Department of Ophthalmology, Copenhagen University Hospital—Rigshospitalet, 2100 Copenhagen, Denmark
2 Department of Clinical Medicine, University of Copenhagen, 2200 Copenhagen, Denmark
3 Department of Neonatal and Pediatric Intensive Care—Rigshospitalet, 2100 Copenhagen, Denmark
AuthorAffiliation_xml – name: 3 Department of Neonatal and Pediatric Intensive Care—Rigshospitalet, 2100 Copenhagen, Denmark
– name: 1 Department of Ophthalmology, Copenhagen University Hospital—Rigshospitalet, 2100 Copenhagen, Denmark
– name: 2 Department of Clinical Medicine, University of Copenhagen, 2200 Copenhagen, Denmark
Author_xml – sequence: 1
  givenname: Hajer A
  orcidid: 0000-0003-2082-3664
  surname: Al-Abaiji
  fullname: Al-Abaiji, Hajer A
  organization: Department of Ophthalmology, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark
– sequence: 2
  givenname: Regitze
  surname: Bangsgaard
  fullname: Bangsgaard, Regitze
  organization: Department of Ophthalmology, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark
– sequence: 3
  givenname: Mads
  orcidid: 0000-0001-9297-7932
  surname: Kofod
  fullname: Kofod, Mads
  organization: Department of Ophthalmology, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark
– sequence: 4
  givenname: Carsten
  surname: Faber
  fullname: Faber, Carsten
  organization: Department of Clinical Medicine, University of Copenhagen, 2200 Copenhagen, Denmark
– sequence: 5
  givenname: Ann-Cathrine
  surname: Larsen
  fullname: Larsen, Ann-Cathrine
  organization: Department of Ophthalmology, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark
– sequence: 6
  givenname: Agnes Galbo
  surname: Brost
  fullname: Brost, Agnes Galbo
  organization: Department of Ophthalmology, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark
– sequence: 7
  givenname: Carina
  orcidid: 0000-0002-0404-0726
  surname: Slidsborg
  fullname: Slidsborg, Carina
  organization: Department of Ophthalmology, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark
– sequence: 8
  givenname: Kristian
  surname: Klemp
  fullname: Klemp, Kristian
  organization: Department of Ophthalmology, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark
– sequence: 9
  givenname: Morten
  surname: Breindahl
  fullname: Breindahl, Morten
  organization: Department of Neonatal and Pediatric Intensive Care-Rigshospitalet, 2100 Copenhagen, Denmark
– sequence: 10
  givenname: Morten Dornonville de
  surname: la Cour
  fullname: la Cour, Morten Dornonville de
  organization: Department of Clinical Medicine, University of Copenhagen, 2200 Copenhagen, Denmark
– sequence: 11
  givenname: Line
  orcidid: 0000-0002-9375-1510
  surname: Kessel
  fullname: Kessel, Line
  organization: Department of Clinical Medicine, University of Copenhagen, 2200 Copenhagen, Denmark
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39452528$$D View this record in MEDLINE/PubMed
BookMark eNptkk1vEzEQhi1UREvoiTuyxKUIpYy_9uOEqtICUqVGVe6W1zubOOzawd6t1H-PQ0pJEfbBo_HzvvbY85oc-eCRkLcMzoWo4dNmOzDJgAGHF-SEQ6nmUvLi6CA-JqcpbSCPSnFewCtyLGqpuOLVCcGre9NPZnR-Rcc10ms0yTWud-MDDR01dIk9JhsR_Q5ZxLCKZqBdiPQOsypszbj-jS4iDmac4k55dne7-ECdp1_QDyb-eENedqZPePq4zsjy-mp5-W1-c_v1--XFzdzyCmDORaHqzqJiYBFsy6FtDbM5Y4ELpUCCzXFtmrJiIm8BKlE00rZNJRDFjHze226nZsDWoh-j6fU2unyJBx2M0893vFvrVbjXjCmo6rLMDmePDjH8nDCNenDJYt8bj2FKWjAOBYCsWUbf_4NuwhR9Lm9PlaIS4i-1Mj1q57uQD7Y7U31RMSkBRC5tRs7_Q-XZ4uBs_vHO5fwzwce9wMaQUsTuqUgGetcY-qAxMv3u8F2e2D9tIH4BIkO0Lw
Cites_doi 10.1001/jamaophthalmol.2014.1604
10.1542/peds.2018-3061
10.1097/IAE.0b013e31816a5587
10.1089/tmj.2020.0010
10.3928/23258160-20201223-03
10.1111/jpc.16621
10.1016/j.ophtha.2021.07.014
10.1136/bjo.68.10.690
10.1001/archopht.123.7.991
10.1136/bjophthalmol-2011-300321
10.1016/j.ophtha.2016.04.035
10.2307/2529310
10.1136/bjo.2008.148908
10.1111/ceo.13593
10.1038/s41598-022-08680-5
10.1001/jamaophthalmol.2024.0045
10.1016/j.jaapos.2016.08.004
10.1136/bjophthalmol-2011-300573
10.1177/1357633X20958240
10.1016/j.preteyeres.2020.100900
10.1016/j.jaapos.2019.08.279
10.1016/j.jaapos.2020.01.014
10.1001/archopht.126.4.493
10.4103/sjopt.sjopt_220_21
10.1177/1357633X19880113
10.3390/jcm11010039
10.1016/S1084-2756(03)00119-2
10.1136/bmjopen-2019-036483
10.1016/j.ophtha.2020.12.024
ContentType Journal Article
Copyright COPYRIGHT 2024 MDPI AG
2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2024 by the authors. 2024
Copyright_xml – notice: COPYRIGHT 2024 MDPI AG
– notice: 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2024 by the authors. 2024
DBID NPM
AAYXX
CITATION
8FE
8FH
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
GNUQQ
HCIFZ
LK8
M7P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.3390/jpm14101020
DatabaseName PubMed
CrossRef
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
ProQuest Central Student
SciTech Premium Collection
ProQuest Biological Science Collection
Biological Science Database
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
Publicly Available Content Database
ProQuest Central Student
ProQuest Biological Science Collection
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
Biological Science Database
ProQuest SciTech Collection
ProQuest Central China
ProQuest Central
ProQuest One Academic UKI Edition
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest One Academic
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef
PubMed


Publicly Available Content Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2075-4426
ExternalDocumentID A814400302
10_3390_jpm14101020
39452528
Genre Journal Article
GeographicLocations Denmark
United States--US
GeographicLocations_xml – name: Denmark
– name: United States--US
GrantInformation_xml – fundername: Aase og Ejnar Danielsens Fond
  grantid: NA
– fundername: Mette Warburgs foundation
  grantid: NA
– fundername: Dagmar Marshalls Fond
  grantid: NA
– fundername: Synoptik-Fonden
  grantid: NA
– fundername: Fabrikant Ejnar Willumsens Mindelegat
  grantid: NA
– fundername: The Danish Eye Research Foundation (Øjenfonden)
  grantid: NA
– fundername: Fight for sight, Denmark (Værn om Synet)
  grantid: NA
– fundername: Aase og Ejnar Danielsens Fond
  grantid: 23-10-0403
– fundername: Fabrikant Ejnar Willumsens Mindelegat
  grantid: 500028
– fundername: Synoptik-Fonden; Fight for sight, Denmark (Værn om Synet); The Danish Eye Research Foundation (Øjenfonden)
– fundername: Mette Warburgs foundation; Dagmar Marshalls Fond
GroupedDBID 53G
5VS
8FE
8FH
AADQD
AAFWJ
ADBBV
AFKRA
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
CCPQU
DIK
EMOBN
GROUPED_DOAJ
GX1
HCIFZ
HYE
IAO
IHR
ITC
KQ8
LK8
M48
M7P
MODMG
M~E
NPM
OK1
PGMZT
PIMPY
PROAC
RIG
RPM
AAYXX
CITATION
ABUWG
AZQEC
DWQXO
GNUQQ
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c2800-23659fce510ce0cd20dda1cfcec02355040ccec9ab7813da10e536b4cdb83ee3
IEDL.DBID RPM
ISSN 2075-4426
IngestDate Mon Oct 28 05:43:01 EDT 2024
Sun Oct 27 16:44:34 EDT 2024
Sat Oct 26 02:49:24 EDT 2024
Tue Nov 19 21:27:11 EST 2024
Tue Nov 12 23:34:06 EST 2024
Fri Nov 22 01:56:34 EST 2024
Sat Nov 02 12:08:36 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords prematurity
telescreening
imaging
non-physician healthcare professional
retinopathy of prematurity
Language English
License Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2800-23659fce510ce0cd20dda1cfcec02355040ccec9ab7813da10e536b4cdb83ee3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-0404-0726
0000-0002-9375-1510
0000-0001-9297-7932
0000-0003-2082-3664
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11508977/
PMID 39452528
PQID 3120673833
PQPubID 2032376
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11508977
proquest_miscellaneous_3120600491
proquest_journals_3120673833
gale_infotracmisc_A814400302
gale_infotracacademiconefile_A814400302
crossref_primary_10_3390_jpm14101020
pubmed_primary_39452528
PublicationCentury 2000
PublicationDate 20240924
PublicationDateYYYYMMDD 2024-09-24
PublicationDate_xml – month: 9
  year: 2024
  text: 20240924
  day: 24
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Journal of personalized medicine
PublicationTitleAlternate J Pers Med
PublicationYear 2024
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Li (ref_6) 2021; 82
Quinn (ref_11) 2014; 132
Fierson (ref_23) 2018; 142
Good (ref_22) 2004; 102
Raileanu (ref_17) 2024; 60
ref_32
Tan (ref_19) 2022; 36
ref_30
Landis (ref_25) 1977; 33
Trese (ref_8) 2008; 28
Athikarisamy (ref_18) 2020; 10
Greenwald (ref_16) 2020; 24
Maka (ref_28) 2021; 27
Smith (ref_4) 2003; 8
Fledelius (ref_5) 2004; 166
Simkin (ref_13) 2019; 47
ref_21
Coyner (ref_34) 2024; 142
ref_1
Ho (ref_14) 2020; 28
ref_3
Campbell (ref_15) 2016; 123
ref_2
Brady (ref_10) 2020; 26
ref_27
Liu (ref_33) 2019; 23
ref_26
Jackson (ref_7) 2008; 126
Sanghi (ref_24) 2012; 96
Slidsborg (ref_31) 2012; 96
Morrison (ref_12) 2016; 20
Pasricha (ref_29) 2021; 52
Fan (ref_20) 2021; 128
Dhaliwal (ref_9) 2009; 93
References_xml – volume: 132
  start-page: 1178
  year: 2014
  ident: ref_11
  article-title: Validity of a Telemedicine System for the Evaluation of Acute-Phase Retinopathy of Prematurity
  publication-title: JAMA Ophthalmol.
  doi: 10.1001/jamaophthalmol.2014.1604
  contributor:
    fullname: Quinn
– volume: 142
  start-page: e20183061
  year: 2018
  ident: ref_23
  article-title: Screening examination of premature infants for retinopathy of prematurity
  publication-title: Pediatrics
  doi: 10.1542/peds.2018-3061
  contributor:
    fullname: Fierson
– volume: 28
  start-page: S1
  year: 2008
  ident: ref_8
  article-title: What is the real gold standard for ROP screening?
  publication-title: Retina
  doi: 10.1097/IAE.0b013e31816a5587
  contributor:
    fullname: Trese
– volume: 26
  start-page: 556
  year: 2020
  ident: ref_10
  article-title: Telemedicine for Retinopathy of Prematurity
  publication-title: Telemed. e-Health
  doi: 10.1089/tmj.2020.0010
  contributor:
    fullname: Brady
– volume: 52
  start-page: 11
  year: 2021
  ident: ref_29
  article-title: Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP): Truly Mobile Teleophthalmology
  publication-title: Ophthalmic Surg Lasers Imaging Retin.
  doi: 10.3928/23258160-20201223-03
  contributor:
    fullname: Pasricha
– volume: 60
  start-page: 369
  year: 2024
  ident: ref_17
  article-title: Excellent accuracy of trained neonatal nurses in the detection of referral-warranted retinopathy of prematurity within an established telemedicine screening programme
  publication-title: J. Paediatr. Child Health
  doi: 10.1111/jpc.16621
  contributor:
    fullname: Raileanu
– ident: ref_26
– ident: ref_3
  doi: 10.1016/j.ophtha.2021.07.014
– ident: ref_1
  doi: 10.1136/bjo.68.10.690
– volume: 102
  start-page: 233
  year: 2004
  ident: ref_22
  article-title: Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial
  publication-title: Trans. Am. Ophthalmol. Soc.
  contributor:
    fullname: Good
– ident: ref_2
  doi: 10.1001/archopht.123.7.991
– volume: 166
  start-page: 4360
  year: 2004
  ident: ref_5
  article-title: Behandlingskrævende præmaturitetsretinopati i Danmark (Danish)
  publication-title: J. Dan. Med. Assoc.
  contributor:
    fullname: Fledelius
– volume: 96
  start-page: 519
  year: 2012
  ident: ref_24
  article-title: A hybrid form of retinopathy of prematurity
  publication-title: Br. J. Ophthalmol.
  doi: 10.1136/bjophthalmol-2011-300321
  contributor:
    fullname: Sanghi
– volume: 123
  start-page: 1795
  year: 2016
  ident: ref_15
  article-title: Diagnostic Discrepancies in Retinopathy of Prematurity Classification
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2016.04.035
  contributor:
    fullname: Campbell
– volume: 33
  start-page: 159
  year: 1977
  ident: ref_25
  article-title: The Measurement of Observer Agreement for Categorical Data
  publication-title: Biometrics
  doi: 10.2307/2529310
  contributor:
    fullname: Landis
– volume: 93
  start-page: 355
  year: 2009
  ident: ref_9
  article-title: Wide-field digital retinal imaging versus binocular indirect ophthalmoscopy for retinopathy of prematurity screening: A two-observer prospective, randomised comparison
  publication-title: Br. J. Ophthalmol.
  doi: 10.1136/bjo.2008.148908
  contributor:
    fullname: Dhaliwal
– volume: 47
  start-page: 1122
  year: 2019
  ident: ref_13
  article-title: Auckland regional telemedicine retinopathy of prematurity screening network: A 10-year review
  publication-title: Clin. Exp. Ophthalmol.
  doi: 10.1111/ceo.13593
  contributor:
    fullname: Simkin
– ident: ref_30
  doi: 10.1038/s41598-022-08680-5
– ident: ref_21
– volume: 142
  start-page: 327
  year: 2024
  ident: ref_34
  article-title: Multinational External Validation of Autonomous Retinopathy of Prematurity Screening
  publication-title: JAMA Ophthalmol.
  doi: 10.1001/jamaophthalmol.2024.0045
  contributor:
    fullname: Coyner
– volume: 20
  start-page: 481
  year: 2016
  ident: ref_12
  article-title: Impact of number and quality of retinal images in a telemedicine screening program for ROP: Results from the e-ROP study
  publication-title: J. Am. Assoc. Pediatr. Ophthalmol. Strabismus
  doi: 10.1016/j.jaapos.2016.08.004
  contributor:
    fullname: Morrison
– volume: 96
  start-page: 549
  year: 2012
  ident: ref_31
  article-title: Experts do not agree when to treat retinopathy of prematurity based on plus disease
  publication-title: Br. J. Ophthalmol.
  doi: 10.1136/bjophthalmol-2011-300573
  contributor:
    fullname: Slidsborg
– volume: 28
  start-page: 502
  year: 2020
  ident: ref_14
  article-title: Evaluation of real-time video from the digital indirect ophthalmoscope for telemedicine consultations in retinopathy of prematurity
  publication-title: J. Telemed. Telecare
  doi: 10.1177/1357633X20958240
  contributor:
    fullname: Ho
– volume: 82
  start-page: 100900
  year: 2021
  ident: ref_6
  article-title: Digital technology, tele-medicine and artificial intelligence in ophthalmology: A global perspective
  publication-title: Prog. Retin. Eye Res.
  doi: 10.1016/j.preteyeres.2020.100900
  contributor:
    fullname: Li
– ident: ref_27
– volume: 23
  start-page: 332.e1
  year: 2019
  ident: ref_33
  article-title: Treatment of non–type 1 retinopathy of prematurity in the Postnatal Growth and Retinopathy of Prematurity (G-ROP) study
  publication-title: J. AAPOS
  doi: 10.1016/j.jaapos.2019.08.279
  contributor:
    fullname: Liu
– volume: 24
  start-page: 160
  year: 2020
  ident: ref_16
  article-title: Evaluation of artificial intelligence-based telemedicine screening for retinopathy of prematurity
  publication-title: J. AAPOS
  doi: 10.1016/j.jaapos.2020.01.014
  contributor:
    fullname: Greenwald
– volume: 126
  start-page: 493
  year: 2008
  ident: ref_7
  article-title: Cost-Utility Analysis of Telemedicine and Ophthalmoscopy for Retinopathy of Prematurity Management
  publication-title: Arch. Ophthalmol.
  doi: 10.1001/archopht.126.4.493
  contributor:
    fullname: Jackson
– volume: 36
  start-page: 283
  year: 2022
  ident: ref_19
  article-title: Retinopathy of prematurity screening: A narrative review of current programs, teleophthalmology, and diagnostic support systems
  publication-title: Saudi J. Ophthalmol.
  doi: 10.4103/sjopt.sjopt_220_21
  contributor:
    fullname: Tan
– volume: 27
  start-page: 367
  year: 2021
  ident: ref_28
  article-title: The validity of telemedicine-based screening for retinopathy of prematurity in the Premature Eye Rescue Program in Hungary
  publication-title: J. Telemed. Telecare
  doi: 10.1177/1357633X19880113
  contributor:
    fullname: Maka
– ident: ref_32
  doi: 10.3390/jcm11010039
– volume: 8
  start-page: 469
  year: 2003
  ident: ref_4
  article-title: Pathogenesis of retinopathy of prematurity
  publication-title: Semin. Neonatol.
  doi: 10.1016/S1084-2756(03)00119-2
  contributor:
    fullname: Smith
– volume: 10
  start-page: e036483
  year: 2020
  ident: ref_18
  article-title: Comparison of wide field imaging by nurses with indirect ophthalmoscopy by ophthalmologists for retinopathy of prematurity: A diagnostic accuracy study
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2019-036483
  contributor:
    fullname: Athikarisamy
– volume: 128
  start-page: 1242
  year: 2021
  ident: ref_20
  article-title: Fundus Pigmentation in the Diagnosis and Treatment of Retinopathy of Prematurity
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2020.12.024
  contributor:
    fullname: Fan
SSID ssj0000852260
Score 2.3204808
Snippet : This study investigates the feasibility of implementing telescreening for retinopathy of prematurity (ROP) using the ICON GO widefield camera operated by a...
Objectives: This study investigates the feasibility of implementing telescreening for retinopathy of prematurity (ROP) using the ICON GO® widefield camera...
Objectives: This study investigates the feasibility of implementing telescreening for retinopathy of prematurity (ROP) using the ICON GO[sup.®] widefield...
Objectives : This study investigates the feasibility of implementing telescreening for retinopathy of prematurity (ROP) using the ICON GO ® widefield camera...
SourceID pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 1020
SubjectTerms Birth weight
Cameras
Children
Children & youth
Classification
Eye diseases
Feasibility studies
Gestational age
Local anesthesia
Medical personnel
Neonatal nursing
Onsite
Ophthalmology
Patient safety
Retinopathy
Retrolental fibroplasia
Telemedicine
Title Evaluating the Feasibility of a Telescreening Program for Retinopathy of Prematurity (ROP) in Denmark
URI https://www.ncbi.nlm.nih.gov/pubmed/39452528
https://www.proquest.com/docview/3120673833
https://www.proquest.com/docview/3120600491
https://pubmed.ncbi.nlm.nih.gov/PMC11508977
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT-MwEB5RDmgviNcu4SUjIcEeQp24SZ0jgiIQAiq2h71FtuPsFqhbFXrg3zOTR5Vw5BbFEyUajzPfyJ-_ATiJeKhDHnHf5FHs97SK_aTHlZ9HmIv7Ode6kMy_-dN_-CuvBiSTE9dnYQrSvtHjc_c6OXfj_wW3cjYx3Zon1h3eXxKKkQhcuh3oIDhs1OjPJfMKMQUvD-MJrOm7z7MJ0Rkxl1LjN5HQXh61X29koq__40ZCapMlG9nnegPWK9jILsrP24QV67Zg7b7aGN8GO6hUu90_hpCOIbKreK8fbJozxUaWhJuIZEMmw5KVxRCxsic69DylzsSF6XBOKq5FTzt29vQ4_M3Gjl1ZN1Hzlx0YXQ9Glzd-1UHBNyEiQT8UcZTkxuLCM5abLORZpgKDdwzp3ES4gg1eJ0r3ZSBwiNtIxLpnMpwia8VPWHVTZ3eBYV3FpZFaSh30LBc6wpLcKCVznZiMaw9Oamems1InI8X6gtyfNtzvwSk5OqXVg940qjoEgC8hHar0QtJmM_54Qg8OWpYY9aY9XE9VWq26t1QEJEaPNbfw4Hg5TE8Sk8zZ6aKyoboo8OBXObPLD64jwwPZmvOlAWlxt0cwRAtN7jok977_6D78CBEx-cWW1wGsvs8X9hA6b9niCLH-7d1REeafKMkCaQ
link.rule.ids 230,315,729,782,786,887,27933,27934,53800,53802
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9tAEB4VKpVeSh_QuoSylZDaHkzW3thZHyMICiqhEc2hN2t3vW4DZBMFcuDfd8aPyObIzfLMypZnxjOj_fYbgOOIhzrkEfdNHsV-T6vYT3pc-XmEubifc60LyvzR7_7VH3k2JJqcuD4LU4D2jZ6duLv5iZv9K7CVy7np1jix7mR8SlWMxMKluwUvMWA5b3TpNyX2CqsKXh7HE9jVd2-WcwI0Yjal0W8iod08GsDeyEVP_8iNlNSGSzbyz_nuc9_8LbypKk42KOXv4IV17-HVuNpT_wB2WBF-u78Mq0GGRWEFmX1ki5wpNrXE-UT4HFKZlIAuhsUuu6bz0gsaalyoTlZEAFuMw2Pfr39NfrCZY2fWzdXqdg-m58Pp6civhi_4JsQv6ocijpLcWIxZY7nJQp5lKjB4xxBFToTBb_A6UbovA4EibiMR657J0LrWin3YdgtnPwHDloxLI7WUOuhZLnSE3bxRSuY6MRnXHhzXVkiXJcVGiq0J2S1t2M2Db2ShlAIPzWBUdX4AH0IUVulA0j41_rNCDzotTQwY0xbXNk6rgL1PRUA89tiuCw--bsS0kkBozi7WlQ61VIEHH0uX2Lxw7VIeyJazbBSIxrstQR8p6Lxrn_j8_KVHsDOaji_Ty4urnwfwOsTCyy92zjqw_bBa20PYus_WX4oo-Q_HxBcv
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9swDCb6AIpdtu7VeW03DSiw7eBatuJE7q1oEnToY0aXw26GJMttukUJ0uWwf1_Sj8DesbsFFo0YICl-hD59BDiKeaQjHnPfFHHf72nV95MeV34RYy0eFFzrUjL__Mfg-qccjkgm56S5C1OS9o2eHrvfs2M3vSu5lYuZCRqeWJBenRGKkQhcgkVeBJuwjUnLo1anfl_xrxBZ8OpKnsDOPrhfzIjUiBWVxr-JhE70aAh7qx79uyu3ylKXMtmqQeMX__P1u_C8Rp7stLJ5CRvWvYKdq_ps_TXYUS387W4ZokKG4LCmzv5l84IpNrGk_UQ8HTJJK2IXQ9DLbuje9JyGG5em6ZKEYMuxeOzLzff0K5s6NrRuppa_3sBkPJqcnfv1EAbfRAgm_Uj046QwFnPXWG7yiOe5Cg0-MSSVE-MmYPB3ovRAhgKXuI1FX_dMjl62VryFLTd39h0wbM24NFJLqcOe5ULH2NUbpWShE5Nz7cFR44lsUUltZNiikO-ylu88-ExeyigB0RVG1fcI8E9Iyio7lXRejXtX5MFBxxITx3SXGz9ndeI-ZCIkPXts24UHn9bL9CaR0Zydr2obaq1CD_aqsFh_cBNWHshOwKwNSM67u4JxUsp6N3Hx_umvfoSddDjOLr9dX-zDswjxl18eoB3A1p_lyh7C5kO--lAmyiOIxRmv
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluating+the+Feasibility+of+a+Telescreening+Program+for+Retinopathy+of+Prematurity+%28ROP%29+in+Denmark&rft.jtitle=Journal+of+personalized+medicine&rft.au=Al-Abaiji%2C+Hajer+A&rft.au=Bangsgaard%2C+Regitze&rft.au=Kofod%2C+Mads&rft.au=Faber%2C+Carsten&rft.date=2024-09-24&rft.pub=MDPI+AG&rft.eissn=2075-4426&rft.volume=14&rft.issue=10&rft.spage=1020&rft_id=info:doi/10.3390%2Fjpm14101020&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2075-4426&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2075-4426&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2075-4426&client=summon